After adjusting for demographics, comorbidities, bleeding severity, and antiplatelet/anticoagulant usage, an increase in the 30-day mortality was still observed during the pandemic, but it did not reach statistical significance (adjusted OR, 1.33; 95% CI, 0.52–3.39, p = 0.550).
← all excerpts
The Effects of COVID-19 on Clinical Outcomes of Non-COVID-19 Patients Hospitalized for Upper Gastrointestinal Bleeding during the Pandemic.
1
0.5500
0.5500